Existing studies have indicated that FAM72B is overexpressed in various tumor types, including OSCC, clear cell renal cell carcinoma (ccRCC), LUAD, and glioblastoma multiform (GBM). Here, FAM72B is linked to nonpapillary renal cell carcinoma.